374 research outputs found
Definições para a padronização da pesquisa de auto-anticorpos contra constituintes do núcleo (FAN HEp-2), nucléolo, citoplasma e aparelho mitótico e suas associações clínicas
OBJECTIVE: The Second Brazilian Consensus on Antinuclear Antibodies (ANA) in HEp-2 Cells approved and extended the decision trees developed during the First Brazilian Consensus in order to also offer information about mixed patterns of fluorescence. METHODS: Since this test elicits reactions not only to nuclear autoimmune antigens but also to different cell compartments, new denominations for the test were approved. Results and CONCLUSIONS: These new denominations encompass variations on the autoantibody testing against the nucleus (ANA HEp-2), nucleolus, cytoplasm, and mitotic apparatus issue. Furthermore, major clinical associations were described for each immunofluorescent pattern, facilitating the interpretation of laboratory results in the clinical practice.OBJETIVO: O Segundo Consenso Brasileiro de Fator Antinuclear (FAN) em Células HEp-2 ratificou os algoritmos de decisão para leitura dos padrões do FAN na imunofluorescência indireta vistos na primeira edição do Consenso Brasileiro, adicionando ainda um novo algoritmo relacionado com os padrões mistos. MÉTODOS: Tendo em vista a habilidade do teste em detectar autoantígenos nos distintos compartimentos celulares, e não apenas no núcleo, propõe-se novas denominações para este exame laboratorial. RESULTADOS E CONCLUSÕES: Como novas denominações algumas sugestões foram igualmente aceitas, dentro do tema pesquisa de auto-anticorpos contra constituintes do núcleo (FAN HEp-2), nucléolo, citoplasma e aparelho mitótico. Foram abordadas as principais relevâncias clínicas com os padrões de FAN descritos, facilitando o melhor uso do ensaio pelo médico.FMUSPUNIFESPBio-Rad Laboratório BrasilHospital Geral de GoiâniaBiomédicaUniversidade Federal de UberlândiaUFMG HCPUCRS HCNew Life Produtos HospitalaresUniversidade Católica de GoiásFMUSP HC Laboratório CentralPatologista ClínicaFMUSP HCFrischmann Aisengart Unidad InmunologíaUniversidade Católica de Goiás Laboratório de Auto-ImunidadeExame Medicina LaboratorialFMUFG HC Laboratório de Imuno-Reumatologia e HLALab. Santa LuziaMedivax/BionHSPE/SPUniversidade Católica de Goiás Laboratório da Área de SaúdeFarmacêutica-BioquímicaUniv. Fed. Mato GrossoFMUFG Serviço de ReumatologiaHospital Durand Unidad InmunologíaLaboratório ClínicoUFRGS HCPA Serviço de ReumatologiaUERJ FCMUFMG FMHospital Universitário de Brasília Laboratório de ReumatologiaUNIFESPSciEL
Clinical relevance of HEp-2 indirect immunofluorescent patterns:the International Consensus on ANA patterns (ICAP) perspective
International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results
The International Consensus on ANA Patterns (ICAP) was initiated as a workshop aiming to thoroughly discuss and achieve consensus regarding the morphological patterns observed in the indirect immunofluorescence assay on HEp-2 cells. One of the topics discussed at the second ICAP workshop, and addressed in this paper, was the harmonization of reporting ANA test results. This discussion centered on the issue if cytoplasmic and mitotic patterns should be reported as positive or negative. This report outlines the issues that impact on two major different reporting methods. Although it was appreciated by all participants that cytoplasmic and mitotic patterns are clinically relevant, implications for existing diagnostic/classification criteria for ANA-associated diseases in particular hampered a final consensus on this topic. Evidently, a more concerted action of all relevant stake-holders is required. Future ICAP workshops may help to facilitate this action.Central Diagnostic LaboratoryMaastricht University Medical Center Maastricht NetherlandsBrazilian Society of Autoimmunity Porto Alegre BrazilDepartment of Immunology and Rheumatology, Hospital General de Occidente University of Guadalajara Guadalajara MexicoLaboratory of Immunology Hospital Carlos G. Durand Buenos Aires ArgentinaDepartment of Immunology Instituto Universitario del Hospital ItalianoBuenos Aires ArgentinaPontifícia Universidade Católica de Goiás Goiânia BrazilDepartment of Medicine, Cumming School of Medicine University of Calgary Calgary CanadaDepartment of Internal Medicine VI Medical University of Innsbruck Innsbruck AustriaDepartment of the Control for Rheumatic Diseases, Graduate School of Medicine Kyoto University Kyoto JapanDepartment of Rheumatology and Clinical Immunology, Graduate School of Medicine Kyoto University Kyoto JapanDepartment of Clinical Nursing University of Occupational and Environmental Health Kitakyushu JapanRheumatology Division, Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo BrazilFleury Medicine and Health Laboratories, Immunology Division São Paulo BrazilDepartment of Oral Biology University of Florida Gaines ville USAInstitute of Immunology Technical University of Dresden Dresden GermanyRheumatology Division, Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo BrazilWeb of Scienc
Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP
Objectives: Antinuclear antibodies (ANA) are important for the diagnosis of various autoimmune diseases. ANA are usually detected by indirect immunofluorescence assay (IFA) using HEp-2 cells (HEp-2 IFA). There are many variables influencing HEp-2 IFA results, such as subjective visual reading, serum screening dilution, substrate manufacturing, microscope components and conjugate. Newer developments on ANA testing that offer novel features adopted by some clinical laboratories include automated computer-assisted diagnosis (CAD) systems and solid phase assays (SPA). Methods: A group of experts reviewed current literature and established recommendations on methodological aspects of ANA testing. This process was supported by a two round Delphi exercise. International expert groups that participated in this initiative included (i) the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “Autoimmunity Testing”; (ii) the European Autoimmune Standardization Initiative (EASI); and (iii) the International Consensus on ANA Patterns (ICAP). Results: In total, 35 recommendations/statements related to (i) ANA testing and reporting by HEp-2 IFA; (ii) HEp-2 IFA methodological aspects including substrate/conjugate selection and the application of CAD systems; (iii) quality assurance; (iv) HEp-2 IFA validation/verification approaches and (v) SPA were formulated. Globally, 95% of all submitted scores in the final Delphi round were above 6 (moderately agree, agree or strongly agree) and 85% above 7 (agree and strongly agree), indicating strong international support for the proposed recommendations. Conclusions: These recommendations are an important step to achieve high quality ANA testing
II brazilian consensus on antinuclear antibodies in HEp-2 cells : definitions for standardizartion of autoantibody testing against the nucleus (ANA HEp-2), nucleolus, cytoplasm and mitotic apparatus, as wel as its clinical associations
Objetivo: O Segundo Consenso Brasileiro de Fator Antinuclear (FAN) em Células HEp-2 ratificou os algoritmos de decisão para leitura dos padrões do FAN na imunofluorescência indireta vistos na primeira edição do Consenso Brasileiro, adicionando ainda um novo algoritmo relacionado com os padrões mistos. Métodos: Tendo em vista a habilidade do teste em detectar autoantígenos nos distintos compartimentos celulares, e não apenas no núcleo, propõe-se novas denominações para este exame laboratorial. Resultados e Conclusões: Como novas denominações algumas sugestões foram igualmente aceitas, dentro do tema “pesquisa de auto-anticorpos contra constituintes do núcleo (FAN HEp-2), nucléolo, citoplasma e aparelho mitótico”. Foram abordadas as principais relevâncias clínicas com os padrões de FAN descritos, facilitando o melhor uso do ensaio pelo médico.Objective: The Second Brazilian Consensus on Antinuclear Antibodies (ANA) in HEp-2 Cells approved and extended the decision trees developed during the First Brazilian Consensus in order to also offer information about mixed patterns of fluorescence. Methods: Since this test elicits reactions not only to nuclear autoimmune antigens but also to different cell compartments, new denominations for the test were approved. Results and Conclusions: These new denominations encompass variations on the “autoantibody testing against the nucleus (ANA HEp-2), nucleolus, cytoplasm, and mitotic apparatus” issue. Furthermore, major clinical associations were described for each immunofluorescent pattern, facilitating the interpretation of laboratory results in the clinical practice
Measurement of inclusive J/ pair production cross section in pp collisions at TeV
International audienceThe production cross section of inclusive J/ pairs in pp collisions at a centre-of-mass energy TeV is measured with ALICE. The measurement is performed for J/ in the rapidity interval . The production cross section of inclusive J/ pairs is reported to be nb in this kinematic interval. The contribution from non-prompt J/ (i.e. originated from beauty-hadron decays) to the inclusive sample is evaluated. The results are discussed and compared with data
Inclusive and multiplicity dependent production of electrons from heavy-flavour hadron decays in pp and pPb collisions
International audienceMeasurements of the production of electrons from heavy-flavour hadron decays in pp collisions at TeV at midrapidity with the ALICE detector are presented down to a transverse momentum () of 0.2 GeV and up to GeV, which is the largest momentum range probed for inclusive electron measurements in ALICE. In pPb collisions, the production cross section and the nuclear modification factor of electrons from heavy-flavour hadron decays are measured in the range GeV at TeV. The nuclear modification factor is found to be consistent with unity within the statistical and systematic uncertainties. In both collision systems, first measurements of the yields of electrons from heavy-flavour hadron decays in different multiplicity intervals normalised to the multiplicity-integrated yield (self-normalised yield) at midrapidity are reported as a function of the self-normalised charged-particle multiplicity estimated at midrapidity. The self-normalised yields in pp and pPb collisions grow faster than linear with the self-normalised multiplicity. A strong dependence is observed in pp collisions, where the yield of high- electrons increases faster as a function of multiplicity than the one of low- electrons. The measurement in pPb collisions shows no dependence within uncertainties. The self-normalised yields in pp and pPb collisions are compared with measurements of other heavy-flavour, light-flavour, and strange particles, and with Monte Carlo simulations
Observation of medium-induced yield enhancement and acoplanarity broadening of low- jets from measurements in pp and central PbPb collisions at TeV
International audienceThe ALICE Collaboration reports the measurement of semi-inclusive distributions of charged-particle jets recoiling from a high transverse momentum (high ) hadron trigger in protonproton and central PbPb collisions at TeV. A data-driven statistical method is used to mitigate the large uncorrelated background in central PbPb collisions. Recoil jet distributions are reported for jet resolution parameter , 0.4, and 0.5 in the range GeV and triggerrecoil jet azimuthal separation . The measurements exhibit a marked medium-induced jet yield enhancement at low and at large azimuthal deviation from . The enhancement is characterized by its dependence on , which has a slope that differs from zero by 4.7. Comparisons to model calculations incorporating different formulations of jet quenching are reported. These comparisons indicate that the observed yield enhancement arises from the response of the QGP medium to jet propagation
- …